Idexx Laboratories IDXX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.1B+22.4% | $1.06B+19.3% | $1.03B+18.6% | $985.66M+16.6% | $894.97M+3.3% | ||
| $148.8M+11.0% | $145.18M+11.7% | $140.17M+11.3% | $137.67M+14.0% | $134.1M+15.1% | ||
| $61.74M+2.0% | $60.01M-0.5% | $58.16M-5.1% | $59.65M-1.5% | $60.51M+0.5% | ||
| $141.15M— | $131.2M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $9.48M+15.2% | $8.43M+22.7% | $7.77M+50.3% | $7.48M+37.6% | $8.23M+72.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $25.87M— | $23.43M— | ||
| —— | —— | —— | —— | —— | ||
| $5.27M+419% | $5.03M+242% | $3.68M+20.6% | $1.99M— | $1.02M— | ||
| $1.21B+25.0% | $1.18B+27.2% | $1.09B+18.7% | $905.81M-6.5% | $968.38M+5.1% | ||
| $126.63M+4.9% | $124.68M+3.1% | $124.5M+0.2% | $121.47M-6.7% | $120.68M-3.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$140.17M-8.1% | -$136.24M+34.2% | -$147.95M+25.1% | -$130.45M+34.2% | -$129.73M+32.7% | ||
| $1.17B+7.8% | $1.22B+45.4% | $1.23B+95.1% | $1.21B+173% | $1.08B+378% | ||
| $104.33M+239% | $93.36M+110% | $88.75M+108% | $42.77M-14.8% | $30.81M-44.1% | ||
| $11.67M+80.5% | $7.24M-31.3% | $7.22M-31.6% | $7.36M-30.4% | $6.47M-38.8% | ||
| -$1.05B+1.7% | -$1.16B-32.7% | -$1.04B-39.5% | -$1.02B-104% | -$1.06B-142% | ||
| —— | —— | —— | $7.36M+336% | -$7.79M— | ||
| —— | —— | —— | —— | -$237.62M-183% | ||
| —— | —— | —— | —— | —— | ||
| $9.48M+15.2% | $8.43M+22.7% | $7.77M+50.3% | $7.48M+37.6% | $8.23M+72.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $104.33M+239% | $93.36M+110% | $88.75M+108% | $42.77M-14.8% | $30.81M-44.1% | ||
| —— | —— | —— | $329M+2,450% | $69.5M+138% | ||
| —— | $250M— | $187.5M— | $125M— | $62.5M— | ||
| —— | —— | —— | —— | —— | ||
| $3.37M+105% | $2.74M+76.1% | $1.66M-49.3% | $1.72M-81.1% | $1.65M-81.1% | ||
| —— | $250M— | $187.5M— | $125M— | $62.5M— | ||
| $1.08B+27.8% | $1.06B+30.8% | $963.57M+21.6% | $784.34M-6.5% | $847.7M+6.4% | ||
| $1.08B+27.8% | $1.06B+30.8% | $963.57M+21.6% | $784.34M-6.5% | $847.7M+6.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Idexx Laboratories generate?
- Idexx Laboratories (IDXX) generated $1.2B in operating cash flow over the trailing twelve months.
- What is Idexx Laboratories's free cash flow?
- After $126.6M of capital expenditures, Idexx Laboratories's free cash flow was $1.1B over the trailing twelve months, up 27.8% year over year.
- Where does Idexx Laboratories's cash flow data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
